Combination therapy of essential hypertension with pindolol (Visken) and hydralazine
- 1 January 1975
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 9 (2-3) , 91-93
- https://doi.org/10.1007/bf00614002
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Deterioration in Renal Function after Beta-blockade in Patients with Chronic Renal Failure and HypertensionBMJ, 1974
- Treatment of hypertension with a new beta-blocking agent, pindolol (Visken®)European Journal of Clinical Pharmacology, 1973
- Chronic beta adrenergic blockade in arterial hypertension: Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatmentThe American Journal of Cardiology, 1972
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972
- TREATMENT OF HYPERTENSION WITH PROPRANOLOL AND HYDRALAZINEActa Medica Scandinavica, 1971
- Treatment of Essential Hypertension with a New Vasodilator in Combination with Beta-Adrenergic BlockadeNew England Journal of Medicine, 1970
- Treatment of Hypertension with PropranololBMJ, 1969
- EFFECTS OF BETA-ADRENERGIC BLOCKADE DURING EXERCISE IN HYPERTENSIVE AND ISCHqMIC HEART-DISEASEThe Lancet, 1967
- CLINICAL AND EXPERIMENTAL STUDIES ON THE HYDRALAZINE SYNDROME AND ITS RELATIONSHIP TO SYSTEMIC LUPUS ERYTHEMATOSUSMedicine, 1967
- The Hemodynamic Effects of Hypotensive Drugs in ManCirculation, 1953